BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19592363)

  • 41. Neonatal chronic lung disease in the post-surfactant era.
    Bland RD
    Biol Neonate; 2005; 88(3):181-91. PubMed ID: 16210840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Neonatal pulmonary pathology].
    Magny JF; Dehan M
    Rev Mal Respir; 1988; 5(3):239-47. PubMed ID: 3041497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bubble continuous positive airway pressure, a potentially better practice, reduces the use of mechanical ventilation among very low birth weight infants with respiratory distress syndrome.
    Nowadzky T; Pantoja A; Britton JR
    Pediatrics; 2009 Jun; 123(6):1534-40. PubMed ID: 19482765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for INSURE failure in preterm infants.
    Dani C; Berti E; Barp J
    Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):19-20. PubMed ID: 21089712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exogenous surfactant in neonatal respiratory distress syndrome.
    Cashore WJ
    R I Med; 1995 Jan; 78(1):7-10. PubMed ID: 7873814
    [No Abstract]   [Full Text] [Related]  

  • 46. Does the use of 50% oxygen at birth in preterm infants reduce lung injury?
    Harling AE; Beresford MW; Vince GS; Bates M; Yoxall CW
    Arch Dis Child Fetal Neonatal Ed; 2005 Sep; 90(5):F401-5. PubMed ID: 15863491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lung function tests in neonates and infants with chronic lung disease of infancy: functional residual capacity.
    Hülskamp G; Pillow JJ; Dinger J; Stocks J
    Pediatr Pulmonol; 2006 Jan; 41(1):1-22. PubMed ID: 16331641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
    Wirbelauer J; Speer CP
    J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severe respiratory distress syndrome unresponsive to intensive care treatment--diagnostic and therapeutic considerations.
    Limbach HG; Hasenfus A; Bohle RM; Baghai A; Löffler G; Gortner L; Fries P; Meyer S
    Klin Padiatr; 2011 Sep; 223(5):283-6. PubMed ID: 21294065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia.
    Cogo PE; Zimmermann LJ; Pesavento R; Sacchetto E; Burighel A; Rosso F; Badon T; Verlato G; Carnielli VP
    Crit Care Med; 2003 May; 31(5):1532-8. PubMed ID: 12771629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Acute respiratory distress and bacterial infection in premature infants during the first 24 hours of life].
    Marchal C; Couronne M; Rouquier F; Szwarcberg R; Roos P; Lapierre H
    Ann Pediatr (Paris); 1976 May; 23(5):389-90. PubMed ID: 16104214
    [No Abstract]   [Full Text] [Related]  

  • 52. Gentle ventilation: the new evidence from the SUPPORT, COIN, VON, CURPAP, Colombian Network, and Neocosur Network trials.
    Carlo WA
    Early Hum Dev; 2012 May; 88 Suppl 2():S81-3. PubMed ID: 22633522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of providing vitamin A to the routine pulmonary care of extremely low birth weight infants.
    Moreira A; Caskey M; Fonseca R; Malloy M; Geary C
    J Matern Fetal Neonatal Med; 2012 Jan; 25(1):84-8. PubMed ID: 21740337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhaled NO for preterm infants--getting to yes?
    Stark AR
    N Engl J Med; 2006 Jul; 355(4):404-6. PubMed ID: 16870920
    [No Abstract]   [Full Text] [Related]  

  • 56. Inherited disorders of neonatal lung diseases.
    Yurdakök M
    Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Artificial respiration of premature infants].
    Reiterer F; Kuttnig-Haim M; Ritschl E; Maurer U; Urlesberger B; Müller W
    Wien Klin Wochenschr; 1993; 105(18):511-5. PubMed ID: 8237012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in the pathogenesis and prevention of chronic lung disease of prematurity.
    Bancalari E
    Am J Perinatol; 2001; 18(1):1-9. PubMed ID: 11321240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. More about surfactant, oxygen, caffeine and chronic lung disease.
    Vento M; Curstedt T; Halliday HL; Hallman M; Saugstad OD; Speer CP
    Neonatology; 2014; 105(4):320-2. PubMed ID: 24931323
    [No Abstract]   [Full Text] [Related]  

  • 60. Continuous Positive Airway Pressure to Prevent Neonatal Lung Injury: How Did We Get Here, and How Do We Improve?
    Wright CJ; Polin RA; Kirpalani H
    J Pediatr; 2016 Jun; 173():17-24.e2. PubMed ID: 27025910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.